Multi-center Trial of Percutaneous Pulmonary Valve Implantation With Venus-p (Venus-P)
Multi-center Trial of Percutaneous Pulmonary Valve Implantation Using Venus-P Valve for Patients With Severe Pulmonary Regurgitation and Native Right Ventricular Outflow Tract After Previous Surgical Repair
Sponsor: Fu Wai Hospital, Beijing, China
Listed as NCT02590679, this PHASE2/PHASE3 trial focuses on Pulmonary Regurgitation and Tetralogy of Fallot and remains ongoing. Sponsored by Fu Wai Hospital, Beijing, China, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2/PHASE3
Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE2_PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Unknown Status PHASE2_PHASE3
Status: Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE2_PHASE3
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fu Wai Hospital, Beijing, China
- Huaxi Hospital
- Shanghai Chest Hospital
- Shanghai Children's Medical Center
- Shanghai Zhongshan Hospital
For direct contact, visit the study record on ClinicalTrials.gov .